(NASDAQ: MLEC) Moolec Science Sa's forecast annual revenue growth rate of -25.97% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Moolec Science Sa's revenue in 2026 is $335,108,850.On average, 3 Wall Street analysts forecast MLEC's revenue for 2026 to be $6,394,222, with the lowest MLEC revenue forecast at $6,142,984, and the highest MLEC revenue forecast at $6,582,287. On average, 3 Wall Street analysts forecast MLEC's revenue for 2027 to be $57,274,246, with the lowest MLEC revenue forecast at $55,027,628, and the highest MLEC revenue forecast at $58,958,847.
In 2028, MLEC is forecast to generate $96,857,280 in revenue, with the lowest revenue forecast at $93,052,406 and the highest revenue forecast at $99,703,675.